Condition
C Reactive Protein
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Completed3
Unknown1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06796712Not ApplicableCompleted
BiomeBakery Project
NCT07089381Not ApplicableRecruiting
Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.
NCT03203343Not ApplicableCompleted
Inflammatory Stress Response in Pediatric Inguinal Hernia Repair
NCT01227109Unknown
Procalcitonin as a Marker of Infection in Cancer Patients
NCT00947323Phase 3Completed
Simvastatin for Treating Erectile Dysfunction
Showing all 5 trials